Organism: Homo sapiens
Gene: 38963_i_at
Selected probe(set): 38964_r_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38963_i_at (38964_r_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):2.021696
Number of Samples:13 / 9

Experimental	cutaneous sarcoidosis study 1 (lesional)
	Lesional skin biopsies from patients with acute cutaneous sarcoidosis.
Control	cutaneous sarcoidosis study 1 (non-lesional)
	Non-lesional skin biopsies from patients with acute cutaneous sarcoidosis.

Relative Expression (log2-ratio):1.913187
Number of Samples:4 / 8

Experimental	cutaneous T-cell lymphoma study 1 (tumor phase)
	Lesional skin biopsies from patients with cutaneous T-cell lymphoma in the tumor phase (extranodal).
Control	normal skin tissue
	Skin biopsies from healthy individuals.

Relative Expression (log2-ratio):1.9012613
Number of Samples:13 / 5

Experimental	cutaneous sarcoidosis study 1 (lesional)
	Lesional skin biopsies from patients with acute cutaneous sarcoidosis.
Control	normal skin tissue
	Skin biopsy samples from healthy control subjects.

Relative Expression (log2-ratio):-1.7649984
Number of Samples:5 / 6

Experimental	atopic dermatitis study 21 (non-lesional; whole skin)
	Non-lesional full thickness skin samples isolated from patient with moderate-to-severe atopic dermatitis by laser capture microdissection. Patients' cohort characteristics: 3 males and 2 females; age 27-59 years (mean age: 39.4 years); SCORing of Atopic Dermatitis index (SCORAD) ranging from 45-65; total IgE: 14-1821 kU/l; eosinophilic count: 1.4-11.8 %.
Control	normal skin tissue
	Full thickness skin samples isolated from healthy subjects by laser capture microdissection.

Relative Expression (log2-ratio):-1.6463223
Number of Samples:43 / 4

Experimental	adrenal gland cancer study 4
	Primary tumor tissue samples of the adrenal cortex from patients with adrenocortical carcinoma (ACC).
Control	normal adrenal cortex tissue
	Histological normal adrenal gland cortical tissue samples derived after autopsy.

Relative Expression (log2-ratio):1.4777966
Number of Samples:2 / 4

Experimental	glioma study 17 (glioblastoma; unsorted)
	Brain cells isolated from high grade glioblastoma (grade IV). Tumor tissue was dissociated using enzymatic treatment and all cells were used for RNA isolation.
Control	non-tumor cortical tissue
	Cortical tissue obtained from patients with epilepsy, but without any manifested brain cancer. The tissue was dissociated using enzymatic treatment, but all brain cell types were used for analyses.

Relative Expression (log2-ratio):-1.4594402
Number of Samples:11 / 4

Experimental	small cell lung cancer study 4 (XCL from CDX)
	Xenograft-derived cell lines (XCL) established from a small cell lung carcinoma (SCLC) publicly available cell lines derived xenografts (CDX derived cell lines). Xenografts were grown in the flanks of a nude mice. Obtained cells were cultivated under conventional tissue culture conditions.
Control	small cell lung cancer study 4 (cell line)
	Various small cell lung cancer (SCLC) publicly available cell lines samples.

Relative Expression (log2-ratio):1.4233952
Number of Samples:10 / 11

Experimental	diphenylcyclopropenone study 1 (early)
	Skin biopsy samples of healthy volunteers exposed to diphenylcyclopropenone (diphencyprone; DPCP) for 3 days. ATC code:---
Control	placebo treated skin tissue
	Skin biopsy samples of healthy volunteers exposed to placebo for 3 days.

Relative Expression (log2-ratio):-1.4151735
Number of Samples:5 / 7

Experimental	E. coli study 2
	Monocyte-derived macrophage samples derived from healthy control subjects cultured for 4 hours with 2.5 × 105 heat-killed E. coli.
Control	unstimulated, normal monocyte-derived macrophage sample
	Monocyte-derived macrophage samples derived from healthy control subjects cultured for 4 hours unstimulated.

Relative Expression (log2-ratio):-1.4042683
Number of Samples:3 / 4

Experimental	stem cell differentiation study 50 (IRF6 shRNA; ASC; proerythroblast)
	Proerythroblast differentiated from IRF6 (interferon regulatory factor 6) shRNA transduced hematopoietic stem/progenitor cells (CD34+). CD34+ hematopoietic stem/progenitor cells (HSC) were transduced with lentivirus expressing shRNA targeting IRF6 gene with following differentiation to the erythroid lineage. HSCs were obtained from magnetically sorted G-CSF mobilized peripheral blood mononuclear cells of healthy donors. Cells were expanded in StemSpan SFEM medium supplied with Flt-3 ligand (100 ng/ml), SCF (100 ng/ml), IL-3 (20 ng/ml), IL-6 (20 ng/ml) and penicillin/streptomycin. Cells were harvested for total RNA extraction at the proerythroblast stage of differentiation.
Control	stem cell differentiation study 50 (mock shRNA; ASC; proerythroblast)
	Proerythroblast differentiated from control shRNA transduced hematopoietic stem/progenitor cells (CD34+). CD34+ hematopoietic stem/progenitor cells (HSC) were transduced with lentivirus expressing control shRNA with following differentiation to the erythroid lineage. HSCs were obtained from magnetically sorted G-CSF mobilized peripheral blood mononuclear cells of healthy donors. Cells were expanded in StemSpan SFEM medium supplied with Flt-3 ligand (100 ng/ml), SCF (100 ng/ml), IL-3 (20 ng/ml), IL-6 (20 ng/ml) and penicillin/streptomycin. Cells were harvested for total RNA extraction at the proerythroblast stage of differentiation.